Skip to content
  • ENGLISHENGLISH
  • 繁體中文繁體中文
回首頁回首頁回首頁
  • About Alar
    • Company Profile
    • Leadership Team
    • History & Milestones
  • Products
    • Product Pipeline
    • Contract Manufacturing
  • Media
    • News
    • Events
  • Investors
    • Stock Info
    • Financials
  • Contact Us
MENU Close

2022/12/29 ALA -1300 Received notice of patent allowance from the Mexican Institute of Industrial Property (IMPI), NO: MX/a/2020/008471

2022/12/29 ALA -1300 Received notice of patent allowance from the Mexican Institute of Industrial Property (IMPI), NO: MX/a/2020/008471

  • Post author:alarpharm
  • Post published:1 . 2 . 2023
  • Post category:Media releases

You Might Also Like

2021/10/29 ALA-1000 Received notice of patent allowance from Intellectual Property Office of Vietnam, Application No. 1-2019-01258.

12 . 11 . 2021

2021/08/25 ALA-1000 Receive notice of patent allowance from South Africa-Companies and Intellectual Property Commission Department of Trade and Industry (CIPC), Application No. 2019/00890.

3 . 9 . 2021

2021/04/16 ALA-1000 Receive notice of allowance for patent registration from Korean Intellectual Property Office (Application No. 10-2019-7009185).

21 . 4 . 2021

2021/10/28 Alar Pharmaceuticals Inc. Completes Successful End-of-Phase 2 Meeting with US FDA for ALA-1000 for the Treatment of Opioid Use Disorder

28 . 10 . 2021

2021/11/30 ALA-1000 Received notice of patent allowance from Directorate General of Intellectual Property (DGIP) of Indonesia, Application No. P00201902139..

17 . 12 . 2021
  • News
  • Events
回首頁

ABOUT

  • Company Profile
  • Leadership Team
  • History & Milestones
  • Company Profile
  • Leadership Team
  • History & Milestones

PRODUCTS

  • Product Pipeline
  • Contract Manufacturing
  • Product Pipeline
  • Contract Manufacturing

MEDIA

  • News
  • Events
  • News
  • Events

INVESTORS

  • Stock Info
  • Financials
  • Stock Info
  • Financials

CONTACT US

  • Contact Us
  • Contact Us
  • Contact Us
  • Privacy Policy
Copyright © - 2022 Alar Pharmaceuticals Inc . All right reserved.
Close
  • About Alar
    • Company Profile
    • Leadership Team
    • History&Milestones
  • Products
    • Products Pipeline
    • Contract Manufacturing
  • Media
    • News
    • Events
  • Investors
    • Stock Info
    • Financials
  • Contact Us
    • Contact Us
×

Cart